Correcting the aberrant Fanconi anemia transcriptional program by gene therapy
- PMID: 37288500
- PMCID: PMC10542829
- DOI: 10.3324/haematol.2023.283031
Correcting the aberrant Fanconi anemia transcriptional program by gene therapy
Comment on
-
Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.Haematologica. 2023 Oct 1;108(10):2652-2663. doi: 10.3324/haematol.2022.282418. Haematologica. 2023. PMID: 37021532 Free PMC article.
References
-
- Peake JD, Noguchi E. Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair. Hum Genet. 2022;141(12):1811-1836. - PubMed
-
- Badra Fajardo N, Taraviras S, Lygerou Z. Fanconi anemia proteins and genome fragility: unraveling replication defects for cancer therapy. Trends Cancer. 2022;8(6):467-481. - PubMed
-
- Bonfim C, Ribeiro L, Nichele S, et al. Long-term survival, organ function, and malignancy after hematopoietic stem cell transplantation for Fanconi anemia. Biol Blood Marrow Transplant. 2016;22(7):1257-1263. - PubMed
-
- Rio P, Navarro S, Wang W, et al. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia. Nat Med. 2019;25(9):1396-1401. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
